Literature DB >> 8054131

Bacteriophage prevents destruction of skin grafts by Pseudomonas aeruginosa.

J S Soothill1.   

Abstract

Infection of split skin grafts in guinea-pigs by Pseudomonas aeruginosa 3719 destroys them, and bacteriophage BS24, lytic for strain 3719, protects the grafts. This supports the view that phage could be used to prevent infection of skin grafts applied to the contaminated wounds of burned patients.

Entities:  

Mesh：

Year:  1994        PMID： 8054131     DOI： 10.1016/0305-4179(94)90184-8

Source DB:  PubMed          Journal:  Burns        ISSN： 0305-4179            Impact factor:   2.744


  27 in total

Review 1.  Bacteriophage therapy.

Authors:  A Sulakvelidze; Z Alavidze; J G Morris
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

Review 2.  Pharmacokinetic principles of bacteriophage therapy.

Authors:  Robert J H Payne; Vincent A A Jansen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Phage therapy to control multidrug-resistant Pseudomonas aeruginosa skin infections: in vitro and ex vivo experiments.

Authors:  A Vieira; Y J Silva; A Cunha; N C M Gomes; H-W Ackermann; A Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-10       Impact factor: 3.267

4.  Efficacy of bacteriophage therapy against gut-derived sepsis caused by Pseudomonas aeruginosa in mice.

Authors:  Ryohei Watanabe; Tetsuya Matsumoto; Go Sano; Yoshikazu Ishii; Kazuhiro Tateda; Yoshinobu Sumiyama; Jumpei Uchiyama; Shingo Sakurai; Shigenobu Matsuzaki; Shosuke Imai; Keizo Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

5.  Experimental phage therapy of burn wound infection: difficult first steps.

Authors:  Thomas Rose; Gilbert Verbeken; Daniel De Vos; Maya Merabishvili; Mario Vaneechoutte; Rob Lavigne; Serge Jennes; Martin Zizi; Jean-Paul Pirnay
Journal:  Int J Burns Trauma       Date:  2014-10-26

6.  Experimental bacteriophage protection against Staphylococcus aureus abscesses in a rabbit model.

Authors:  Quintin F Wills; Claire Kerrigan; James S Soothill
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

7.  Isolation of bacteriophages specific to a fish pathogen, Pseudomonas plecoglossicida, as a candidate for disease control.

Authors:  S C Park; I Shimamura; M Fukunaga; K I Mori; T Nakai
Journal:  Appl Environ Microbiol       Date:  2000-04       Impact factor: 4.792

Review 8.  Shaping of cutaneous function by encounters with commensals.

Authors:  Emma Barnard; Huiying Li
Journal:  J Physiol       Date:  2016-04-13       Impact factor: 5.182

9.  Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium.

Authors:  Biswajit Biswas; Sankar Adhya; Paul Washart; Brian Paul; Andrei N Trostel; Bradford Powell; Richard Carlton; Carl R Merril
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

10.  Reduction in exopolysaccharide viscosity as an aid to bacteriophage penetration through Pseudomonas aeruginosa biofilms.

Authors:  G W Hanlon; S P Denyer; C J Olliff; L J Ibrahim
Journal:  Appl Environ Microbiol       Date:  2001-06       Impact factor: 4.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.